| The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’? C Moussion, N Ortega, JP Girard PloS one 3 (10), e3331, 2008 | 1412 | 2008 |
| HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes JP Girard, C Moussion, R Förster Nature Reviews Immunology 12 (11), 762-773, 2012 | 812 | 2012 |
| Interstitial dendritic cell guidance by haptotactic chemokine gradients M Weber, R Hauschild, J Schwarz, C Moussion, I De Vries, DF Legler, ... Science 339 (6117), 328-332, 2013 | 622 | 2013 |
| Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells M Casanova-Acebes, E Dalla, AM Leader, J LeBerichel, J Nikolic, ... Nature 595 (7868), 578-584, 2021 | 393 | 2021 |
| Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules C Moussion, JP Girard Nature 479 (7374), 542-546, 2011 | 324 | 2011 |
| Polysialylation controls dendritic cell trafficking by regulating chemokine recognition E Kiermaier, C Moussion, CT Veldkamp, R Gerardy-Schahn, I De Vries, ... Science 351 (6269), 186-190, 2016 | 161 | 2016 |
| Gremlin 1+ fibroblastic niche maintains dendritic cell homeostasis in lymphoid tissues VN Kapoor, S Müller, S Keerthivasan, M Brown, C Chalouni, EE Storm, ... Nature immunology 22 (5), 571-585, 2021 | 56 | 2021 |
| Blood vessels pattern heparan sulfate gradients between their apical and basolateral aspects L Stoler-Barak, C Moussion, E Shezen, M Hatzav, M Sixt, R Alon PloS one 9 (1), e85699, 2014 | 55 | 2014 |
| Anti-inflammatory effects of an inflammatory chemokine: CCL2 inhibits lymphocyte homing by modulation of CCL21-triggered integrin-mediated adhesions L Flaishon, G Hart, E Zelman, C Moussion, V Grabovsky, G Lapidot Tal, ... Blood, The Journal of the American Society of Hematology 112 (13), 5016-5025, 2008 | 43 | 2008 |
| L-selectin controls trafficking of chronic lymphocytic leukemia cells in lymph node high endothelial venules in vivo F Lafouresse, E Bellard, C Laurent, C Moussion, JJ Fournié, L Ysebaert, ... Blood, The Journal of the American Society of Hematology 126 (11), 1336-1345, 2015 | 42 | 2015 |
| Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity J Svensson-Arvelund, S Cuadrado-Castano, G Pantsulaia, K Kim, ... Nature Communications 13 (1), 7149, 2022 | 37 | 2022 |
| In situ tumour arrays reveal early environmental control of cancer immunity G Ortiz-Muñoz, M Brown, CB Carbone, X Pechuan-Jorge, V Rouilly, ... Nature 618 (7966), 827-833, 2023 | 24* | 2023 |
| Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load DJ Eddins, J Yang, A Kosters, VD Giacalone, X Pechuan-Jorge, ... Blood advances 7 (5), 778-799, 2023 | 24* | 2023 |
| Shape and function of interstitial chemokine CCL21 gradients are independent of heparan sulfates produced by lymphatic endothelium K Vaahtomeri, C Moussion, R Hauschild, M Sixt Frontiers in Immunology 12, 630002, 2021 | 19 | 2021 |
| The dendritic cell strikes back C Moussion, I Mellman Immunity 49 (6), 997-999, 2018 | 18 | 2018 |
| Systematically characterizing the roles of E3-ligase family members in inflammatory responses with massively parallel Perturb-seq K Geiger-Schuller, B Eraslan, O Kuksenko, KK Dey, KA Jagadeesh, ... bioRxiv, 2023.01. 23.525198, 2023 | 11 | 2023 |
| Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy C Moussion, L Delamarre Seminars in Immunology 71, 101848, 2024 | 9 | 2024 |
| A conduit to amplify innate immunity C Moussion, M Sixt Immunity 38 (5), 853-854, 2013 | 9 | 2013 |
| Tumour lymph vessels boost immunotherapy C Moussion, SJ Turley Nature 552 (7685), 340-342, 2017 | 3 | 2017 |
| A novel method to produce synthetic murine CXCL10 for efficient screening of functional variants J Decalf, J Tom, E Mai, H Hernandez-Barry, CL Noland, BS Vollmar, A Li, ... Bioorganic Chemistry 116, 105376, 2021 | 2 | 2021 |
